Parkinson's Disease (PD) is a complex neurodegenerative disorder that affects millions of people worldwide. Healthcare professionals need to understand the intricacies of this disease to provide effective care and management.
The primary pathological hallmark of PD is the loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of Lewy bodies. This leads to a decrease in dopamine levels, resulting in motor and non-motor symptoms characteristic of the disease.
PD typically presents with motor symptoms such as bradykinesia, rigidity, and resting tremor. However, non-motor symptoms including autonomic dysfunction, cognitive impairment, and psychiatric symptoms often precede motor symptoms and significantly impact patients' quality of life.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and response to dopaminergic therapy. Neuroimaging, although not routinely used, can assist in distinguishing PD from other parkinsonian syndromes.
Management of PD is multifaceted, involving pharmacological and non-pharmacological interventions. Dopaminergic medications remain the cornerstone of treatment. However, addressing non-motor symptoms and implementing rehabilitative therapies are equally essential.
Research in PD is focused on understanding the disease's pathogenesis to develop disease-modifying therapies. The role of genetic and environmental factors, neuroinflammation, and gut-brain axis are areas of active investigation.
Understanding PD's pathophysiology, clinical manifestations, diagnostic approach, and management strategies is crucial for healthcare professionals. With ongoing research, there is hope for developing therapies that can alter the disease's course and improve patients' lives.
1.
High Response Rate in Heavily Treated Multiple Myeloma With Novel Drug Combination
2.
Measurable Residual Disease Predicts Real-World AML Relapse
3.
Chemotherapy can be a challenging treatment?here's how to deal with some of the side-effects
4.
Black women are more likely to die of breast cancer. Close the gap by looking into mammogram studies.
5.
Admissions, medical schools, costs, and eligibility requirements information for FNB Head and Neck Oncology.
1.
Modern Developments in Oncology for Specialists
2.
Case-Based Learning: Reasoning Through New Functional Changes During Long-Term Cancer Survivorship
3.
The Latest Advances in Glioblastoma Treatment and Prevention
4.
How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement?
5.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
2.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
4.
Understanding Iron Deficiency and Its Common Symptoms
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation